{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:31:25Z","timestamp":1787959885751,"version":"build-2784847793"},"reference-count":45,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Science and Technology Major Project of Infectious Diseases","award":["2012ZX10004503-005"],"award-info":[{"award-number":["2012ZX10004503-005"]}]},{"name":"the National High Technology Research and Development Program of China","award":["2012AA02A408"],"award-info":[{"award-number":["2012AA02A408"]}]},{"name":"Science and Technology Plan Program of Xiamen City","award":["3502Z20131001"],"award-info":[{"award-number":["3502Z20131001"]}]},{"name":"Science and Technology Plan Program of Xiamen City","award":["3502Z201410045"],"award-info":[{"award-number":["3502Z201410045"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.vaccine.2016.02.007","type":"journal-article","created":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T22:50:26Z","timestamp":1455058226000},"page":"1589-1596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["A highly conserved epitope-vaccine candidate against varicella-zoster virus induces neutralizing antibodies in mice"],"prefix":"10.1016","volume":"34","author":[{"given":"Rui","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunye","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangzhong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfa","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinjian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningshao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.02.007_bib0230","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1099\/0022-1317-67-9-1759","article-title":"The complete DNA-sequence of varicella-zoster virus","volume":"67","author":"Davison","year":"1986","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0235","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/CMR.9.3.361","article-title":"Varicella-zoster virus","author":"Arvin","year":"1996","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0240","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4065\/84.3.274","article-title":"Herpes zoster (shingles) and postherpetic neuralgia","volume":"84","author":"Sampathkumar","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0245","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/CMR.00031-09","article-title":"Impact of varicella vaccine on varicella-zoster virus dynamics","volume":"23","author":"Schmid","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0250","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/10489140-000000000-00000","article-title":"Zoster vaccine (Zostavax (R)) a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults","volume":"27","author":"Sanford","year":"2010","journal-title":"Drug Aging"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0255","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0264-410X(99)00428-4","article-title":"Immunization with a DNA expression vector encoding the varicella tester virus glycoprotein E (gE) gene via intramuscular and subcutaneous routes","volume":"18","author":"Hasan","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0260","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S0264-410X(01)00475-3","article-title":"Immunization with a DNA vaccine expressing a truncated form of varicella zoster virus glycoprotein E","volume":"20","author":"Hasan","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0265","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/infdis\/jit344","article-title":"Safety and immunogenicity of heat-treated zoster vaccine (ZV(HT)) in immunocompromised adults","volume":"208","author":"Mullane","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0270","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/infdis\/jis497","article-title":"A phase 1\/2 clinical trial evaluating safety and immunogenicity of a varicella zoster glycoprotein E subunit vaccine candidate in young and older adults","volume":"206","author":"Leroux-Roels","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0275","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.4161\/hv.24269","article-title":"Safety and immunogenicity of an AS01-adjuvanted varicella zoster virus subunit candidate vaccine (HZ\/su) A phase-I, open-label study in Japanese adults","volume":"9","author":"Lal","year":"2013","journal-title":"Hum Vaccine Immunother"},{"issue":"May (22)","key":"10.1016\/j.vaccine.2016.02.007_bib0280","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0285","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature12966","article-title":"Proof of principle for epitope-focused vaccine design","volume":"507","author":"Correia","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0290","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0952-7915(03)00083-9","article-title":"Epitope-based vaccines: an update on epitope identification, vaccine design and delivery","volume":"15","author":"Sette","year":"2003","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0295","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/vaccines2030515","article-title":"Peptide vaccine: progress and challenges","volume":"2","author":"Li W","year":"2014","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0300","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1128\/JVI.02097-08","article-title":"Characterization of neutralizing epitopes of varicella-zoster virus glycoprotein H","volume":"83","author":"Akahori","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0305","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/JVI.02561-12","article-title":"Human anti-varicella-zoster virus (VZV) recombinant monoclonal antibody produced after Zostavax immunization recognizes the gH\/gL complex and neutralizes VZV infection","volume":"87","author":"Birlea","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0310","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1006\/viro.1995.0064","article-title":"Identification of immunodominant regions and linear B cell epitopes of the gE envelope protein of varicella-zoster virus","volume":"214","author":"Fowler","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0315","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0264-410X(96)00228-9","article-title":"Induction of neutralizing antibody and T-cell responses to varicella-zoster virus (VZV) using Ty-virus-like particles carrying fragments of glycoprotein E (gE)","volume":"15","author":"GarciaValcarcel","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0320","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2144\/97222rr02","article-title":"Epitope mapping and tagging by recombination PCR mutagenesis","volume":"22","author":"Hatfield","year":"1997","journal-title":"Biotechniques"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0325","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1007\/s00253-015-6602-5","article-title":"A monoclonal antibody-based VZV glycoprotein E quantitative assay and its application on antigen quantitation in VZV vaccine","volume":"99","author":"Liu","year":"2015","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0330","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3748\/wjg.v11.i4.492","article-title":"Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus","volume":"11","author":"Yang","year":"2005","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0335","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(06)69561-5","article-title":"Varicella","volume":"368","author":"Heininger","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0340","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1086\/522156","article-title":"Changing varicella epidemiology in active surveillance sites \u2013 United States, 1995\u20132005","volume":"197","author":"Guris","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0345","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0350","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cid\/cir970","article-title":"Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50\u201359 years","volume":"54","author":"Schmader","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0355","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1086\/522127","article-title":"Comparative analyses of the 9 glycoprotein genes found in wild-type and vaccine strains of varicella-zoster virus","volume":"197","author":"Storlie","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.76.1.1-8.2002","article-title":"Directed egress of animal viruses promotes cell-to-cell spread","volume":"76","author":"Johnson","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0365","doi-asserted-by":"crossref","first-page":"12406","DOI":"10.1128\/JVI.78.22.12406-12415.2004","article-title":"Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo","volume":"78","author":"Moffat","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0370","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1128\/JVI.01902-10","article-title":"Varicella-zoster virus glycoprotein E is a critical determinant of virulence in the SCID mouse-human model of neuropathogenesis","volume":"85","author":"Zerboni","year":"2011","journal-title":"J Virol"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2016.02.007_bib0375","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1099\/0022-1317-77-2-211","article-title":"Induction of varicella-zoster virus-neutralizing antibodies in mice by co-infection with recombinant vaccinia viruses expressing the gH or gL gene","volume":"77","author":"Nemeckova","year":"1996","journal-title":"J Gen Virol"},{"issue":"Pt 3","key":"10.1016\/j.vaccine.2016.02.007_bib0380","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1099\/0022-1317-74-3-491","article-title":"Induction of neutralizing antibodies by varicella-zoster virus gpII glycoprotein expressed from recombinant vaccinia virus","volume":"74","author":"Massaer","year":"1993","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0385","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/viro.1998.9313","article-title":"Antigenic variation of varicella zoster virus Fc receptor gE: loss of a major B cell epitope in the ectodomain","volume":"249","author":"Santos","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0390","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3201\/eid0812.020118","article-title":"New variant of varicella-zoster virus","volume":"8","author":"Tipples","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0395","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jcv.2006.06.004","article-title":"A novel mutation of varicella-zoster virus associated to fatal hepatitis","volume":"37","author":"Natoli","year":"2006","journal-title":"J Clin Virol: Off Publ Pan Am Soc Clin Virol"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0400","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/JCM.01735-07","article-title":"Novel varicella-zoster virus glycoprotein E gene mutations associated with genotypes A and D","volume":"46","author":"Schmidt-Chanasit","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0405","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/0264-410X(93)90382-8","article-title":"Antigenicity of a candidate varicella-zoster virus glycoprotein subunit vaccine","volume":"11","author":"Vafai","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0410","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1128\/JVI.69.9.5236-5242.1995","article-title":"Tropism of varicella-zoster virus for human Cd4(+) and Cd8(+) T-lymphocytes and epidermal-cells in Scid-hu mice","volume":"69","author":"Moffat","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0415","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/infdis\/163.4.746","article-title":"Varicella in hairless guinea-pigs","volume":"163","author":"Myers","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0420","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/330381a0","article-title":"Improved immunogenicity of a peptide epitope after fusion to hepatitis-B core protein","volume":"330","author":"Clarke","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0425","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0065-3527(08)60808-8","article-title":"Core particles of hepatitis B virus as carrier for foreign epitopes","volume":"50","author":"Ulrich","year":"1998","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0430","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1515\/BC.1999.047","article-title":"Development of HIV\/AIDS vaccine using chimeric gag-env virus-like particles","volume":"380","author":"Kang","year":"1999","journal-title":"Biol Chem"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0435","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1016\/j.vaccine.2013.07.052","article-title":"A universal virus-like particle-based vaccine for human papillomavirus: longevity of protection and role of endogenous and exogenous adjuvants","volume":"31","author":"Tumban","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0440","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.vaccine.2012.10.083","article-title":"Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development","volume":"31","author":"Kushnir","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0445","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1126\/science.3491425","article-title":"The nucleocapsid of hepatitis-B virus is both a T-cell independent and a T-cell-dependent antigen","volume":"234","author":"Milich","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2016.02.007_bib0450","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1073\/pnas.96.5.1915","article-title":"Native display of complete foreign protein domains on the surface of hepatitis B virus capsids","volume":"96","author":"Kratz","year":"1999","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1600133X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1600133X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T05:32:29Z","timestamp":1600147949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1600133X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":45,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0264410X1600133X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.007","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A highly conserved epitope-vaccine candidate against varicella-zoster virus induces neutralizing antibodies in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}